BRPI0814318A2 - Forma cristalina, composição, e, uso de uma quantidade terapeuticamente eficaz de uma composição - Google Patents

Forma cristalina, composição, e, uso de uma quantidade terapeuticamente eficaz de uma composição

Info

Publication number: BRPI0814318A2
Authority: BR; Brazil
Prior art keywords: composition; crystalline form; therapeutically efficient; efficient quantity; therapeutically
Prior art date: 2007-07-26

Application number

BRPI0814318-8A2A

Other languages

English (en)

Inventor

Fritz Blatter

Meinrad Brenner

Guixian Hu

Timo Rager

Ralf Warrass

Original Assignee

Intervet Int Bv

Microbial Chem Res Found

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-07-26

Filing date

2008-07-25

Publication date

2015-01-06

2008-07-25 Application filed by Intervet Int Bv, Microbial Chem Res Found filed Critical Intervet Int Bv

2015-01-06 Publication of BRPI0814318A2 publication Critical patent/BRPI0814318A2/pt

2021-04-06 Publication of BRPI0814318B1 publication Critical patent/BRPI0814318B1/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Tropical Medicine & Parasitology (AREA)
Pulmonology (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Medicinal Preparation (AREA)
Epidemiology (AREA)

BRPI0814318-8A 2007-07-26 2008-07-25 Forma cristalina, composição, uso de uma quantidade terapeuticamente eficaz de uma composição, e, composição farmacêutica BRPI0814318B1 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP07113244A EP2019112A1 (en)	2007-07-26	2007-07-26	Macrolide solid-state forms
EP07113244.3		2007-07-26
PCT/EP2008/059775 WO2009013351A2 (en)	2007-07-26	2008-07-25	Macrolide solid-state forms

Publications (2)

Publication Number	Publication Date
BRPI0814318A2 true BRPI0814318A2 (pt)	2015-01-06
BRPI0814318B1 BRPI0814318B1 (pt)	2021-04-06

Family

ID=39467287

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0814318-8A BRPI0814318B1 (pt)	2007-07-26	2008-07-25	Forma cristalina, composição, uso de uma quantidade terapeuticamente eficaz de uma composição, e, composição farmacêutica

Country Status (13)

Country	Link
EP (3)	EP2019112A1 (pt)
JP (7)	JP5925989B2 (pt)
KR (2)	KR20160003899A (pt)
CN (5)	CN101778858B (pt)
AU (1)	AU2008278969B8 (pt)
BR (1)	BRPI0814318B1 (pt)
CA (1)	CA2693801C (pt)
ES (2)	ES2608978T3 (pt)
HU (1)	HUE031449T2 (pt)
RU (1)	RU2476438C2 (pt)
TW (1)	TWI427083B (pt)
WO (1)	WO2009013351A2 (pt)
ZA (1)	ZA201000188B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5323696B2 (ja)	2006-07-28	2013-10-23	インターベツト・インターナシヨナル・ベー・ベー	マクロライド合成方法
EP2019112A1 (en) *	2007-07-26	2009-01-28	Intervet International BV	Macrolide solid-state forms
JP6170064B2 (ja)	2011-11-25	2017-07-26	バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒＩｎｔｅｌｌｅｃｔｕａｌＰｒｏｐｅｒｔｙＧｍｂＨ	抗菌性チロシン誘導体およびその製造方法
CN102816196A (zh) *	2012-09-10	2012-12-12	河北远征药业有限公司	泰地罗新半抗原、人工抗原及其制备方法
NO2999707T3 (pt) *	2013-05-23	2018-08-25
CN103554203A (zh) *	2013-08-17	2014-02-05	齐鲁动物保健品有限公司	一种泰地罗新无定形晶及其制备方法
CN104447919B (zh) *	2014-11-28	2017-03-08	武汉回盛生物科技股份有限公司	一种20，23‑二哌啶基‑5‑o‑碳霉胺糖基‑泰乐内酯原料药的精制方法
CN104478974B (zh) *	2014-11-28	2016-08-17	武汉回盛生物科技有限公司	一种20，23-二哌啶基-5-o-碳霉胺糖基-泰乐内酯的合成方法
CN104497082B (zh) *	2015-01-13	2017-12-12	中国兽医药品监察所	一种泰地罗新的合成方法
CN104774223A (zh) *	2015-03-26	2015-07-15	宁夏泰瑞制药股份有限公司	一种利用泰乐菌素碱生产泰地罗新的方法
CN105254693B (zh) *	2015-11-13	2017-12-22	周金华	一种泰地罗新的合成方法
CN106083958B (zh) *	2016-06-02	2019-07-23	天津大学	泰地罗新环己烷溶剂化合物及制备方法
CN106046084B (zh) *	2016-06-02	2019-08-09	天津大学	泰地罗新丙酮溶剂化合物及制备方法
CN106008629B (zh) *	2016-06-02	2019-11-22	天津大学	泰地罗新1,4-二氧六环溶剂化合物及制备方法
CN109721633A (zh) *	2017-10-31	2019-05-07	齐鲁晟华制药有限公司	一种泰地罗新晶型a及其制备方法
IL280880B2 (en)	2018-08-27	2025-04-01	Regeneron Pharma	Using Raman Spectroscopy in Downstream Purification
CN111349130A (zh) *	2018-12-21	2020-06-30	齐鲁动物保健品有限公司	一种泰地罗新晶型b及其制备方法
EP4255445B1 (en)	2020-12-03	2025-05-14	Intervet International B.V.	Tildipirosin for the treatment of foot rot
CN114213484A (zh) *	2021-12-21	2022-03-22	河北远征药业有限公司	一种泰地罗新1，2-丙二醇溶剂化合物及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL33732A (en) *	1969-02-06	1973-05-31	Meiji Seika Kaisha	The new antibiotics sf-837,sf-837-a2,sf-837-a3 and sf-837-a4 and their production
US4820695A (en)	1982-09-13	1989-04-11	Eli Lilly And Company	C-20-dihydro-deoxy-(cyclic amino)-derivatives of macrolide antibiotics
AU561147B2 (en)	1982-09-13	1987-04-30	Eli Lilly And Company	20-amino macrolide antibiotics
SI8311553A8 (en) *	1983-07-18	1995-06-30	Pliva Pharm & Chem Works	Process for preparing 7,16-dioxa-2-aza-10-0-cladynosil-12-0-desosaminyl-4,5-dihydroxy-6- ethyl-3,5,9,11,13,15-hexamethylbicyclo (11.2.1.) hexadeca-1(2)-ene-8-ones
US4921947A (en) *	1986-03-31	1990-05-01	Eli Lilly And Company	Process for preparing macrolide derivatives
US4920103A (en)	1986-09-29	1990-04-24	Eli Lilly And Company	Modifications of mycinose and 3-O-demethylmycinose in tylosin-type macrolides
ES2213597T3 (es)	1999-08-30	2004-09-01	Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai	Antibioticos macrolidos y tratamiento de la pasteurelosis.
EP3738591A3 (en) *	2003-03-10	2021-03-24	Merck Sharp & Dohme Corp.	Novel antibacterial agents
WO2005019226A1 (en) *	2003-08-26	2005-03-03	Biocon Limited	A process for the recovery of substantially pure tricyclic macrolide
MX2007006119A (es) *	2005-01-05	2007-07-19	Teva Gyogyszergyar Zartkoruen	Tacrolimus amorfo y preparacion de el.
JP5323696B2 (ja) *	2006-07-28	2013-10-23	インターベツト・インターナシヨナル・ベー・ベー	マクロライド合成方法
CN101506220B (zh) *	2006-07-28	2012-10-17	英特威国际有限公司	大环内酯合成方法
EP2019112A1 (en) *	2007-07-26	2009-01-28	Intervet International BV	Macrolide solid-state forms

2007
- 2007-07-26 EP EP07113244A patent/EP2019112A1/en not_active Withdrawn
2008
- 2008-07-08 TW TW097125698A patent/TWI427083B/zh active
- 2008-07-25 ES ES08786436.9T patent/ES2608978T3/es active Active
- 2008-07-25 RU RU2010107057/04A patent/RU2476438C2/ru active
- 2008-07-25 BR BRPI0814318-8A patent/BRPI0814318B1/pt active IP Right Grant
- 2008-07-25 CN CN2008801005518A patent/CN101778858B/zh active Active
- 2008-07-25 AU AU2008278969A patent/AU2008278969B8/en active Active
- 2008-07-25 CN CN201310279877.4A patent/CN103360445B/zh active Active
- 2008-07-25 CN CN201310280229.0A patent/CN103360447B/zh active Active
- 2008-07-25 CA CA2693801A patent/CA2693801C/en active Active
- 2008-07-25 HU HUE08786436A patent/HUE031449T2/en unknown
- 2008-07-25 JP JP2010517412A patent/JP5925989B2/ja active Active
- 2008-07-25 WO PCT/EP2008/059775 patent/WO2009013351A2/en not_active Ceased
- 2008-07-25 EP EP08786436.9A patent/EP2181117B1/en active Active
- 2008-07-25 EP EP16197385.4A patent/EP3170833B1/en active Active
- 2008-07-25 KR KR1020157036690A patent/KR20160003899A/ko not_active Ceased
- 2008-07-25 CN CN201310280228.6A patent/CN103360446B/zh active Active
- 2008-07-25 KR KR1020107003939A patent/KR102508115B1/ko active Active
- 2008-07-25 CN CN2013102805250A patent/CN103467548A/zh active Pending
- 2008-07-25 ES ES16197385T patent/ES2805534T3/es active Active
2010
- 2010-01-11 ZA ZA201000188A patent/ZA201000188B/xx unknown
2013
- 2013-12-05 JP JP2013251788A patent/JP2014088394A/ja active Pending
2016
- 2016-02-10 JP JP2016023658A patent/JP6343624B2/ja active Active
2018
- 2018-02-09 JP JP2018021676A patent/JP2018104449A/ja active Pending
- 2018-02-09 JP JP2018021677A patent/JP2018109020A/ja active Pending
2020
- 2020-07-02 JP JP2020114648A patent/JP2020172516A/ja active Pending
- 2020-07-02 JP JP2020114652A patent/JP2020172517A/ja active Pending

Also Published As

Publication number	Publication date
JP2020172516A (ja)	2020-10-22
BRPI0814318B1 (pt)	2021-04-06
CN101778858B (zh)	2013-12-04
JP5925989B2 (ja)	2016-05-25
JP2020172517A (ja)	2020-10-22
CN103360445A (zh)	2013-10-23
WO2009013351A2 (en)	2009-01-29
JP2010534635A (ja)	2010-11-11
CN103360447A (zh)	2013-10-23
ES2805534T3 (es)	2021-02-12
CN103360446A (zh)	2013-10-23
TW200918547A (en)	2009-05-01
CN103360446B (zh)	2016-04-06
CN101778858A (zh)	2010-07-14
AU2008278969A1 (en)	2009-01-29
EP2181117B1 (en)	2016-11-09
JP2018104449A (ja)	2018-07-05
TWI427083B (zh)	2014-02-21
RU2010107057A (ru)	2011-09-10
CN103360447B (zh)	2016-04-06
AU2008278969B2 (en)	2011-11-17
AU2008278969B8 (en)	2012-03-15
EP2019112A1 (en)	2009-01-28
EP3170833B1 (en)	2020-05-20
RU2476438C2 (ru)	2013-02-27
JP2014088394A (ja)	2014-05-15
CN103360445B (zh)	2016-05-18
JP2016147858A (ja)	2016-08-18
ES2608978T3 (es)	2017-04-17
CA2693801A1 (en)	2009-01-29
CN103467548A (zh)	2013-12-25
JP2018109020A (ja)	2018-07-12
KR20100044864A (ko)	2010-04-30
JP6343624B2 (ja)	2018-06-13
EP2181117A2 (en)	2010-05-05
WO2009013351A3 (en)	2009-04-02
KR20160003899A (ko)	2016-01-11
KR102508115B1 (ko)	2023-03-08
HUE031449T2 (en)	2017-07-28
CA2693801C (en)	2018-08-14
ZA201000188B (en)	2010-09-29
EP3170833A1 (en)	2017-05-24

Publication	Publication Date	Title
BRPI0814318A2 (pt)	2015-01-06	Forma cristalina, composição, e, uso de uma quantidade terapeuticamente eficaz de uma composição
NO2025055I1 (no)	2025-12-10	Clascoterone and crystalline forms thereof
BRPI0821165A2 (pt)	2015-06-16	Uso de uma composição
BRPI0813770A2 (pt)	2014-12-30	Composição, e, uso de uma composição
BRPI0822398B8 (pt)	2018-05-29	forma sólida cristalina e composição farmacêutica que a compreende
EP2212259C0 (de)	2024-03-27	Baustoffzusammensetzung
PT2121537T (pt)	2020-10-26	Novas composições de betão
BRPI0908792A2 (pt)	2015-07-21	Composição, e, uso de uma combinação
BRPI0813775A2 (pt)	2015-01-06	Composição
DK1984009T3 (da)	2013-01-28	Farmaceutiske sammensætninger med forbedret stabilitet
ATE528048T1 (de)	2011-10-15	Schweisshemmende/desodorierende zusammensetzung
BRPI1013421A2 (pt)	2016-04-05	composição parasticida tópica, e, uso de uma composição
BRPI0812592A2 (pt)	2014-11-18	Composição assada
BRPI0811274A2 (pt)	2014-10-07	Composição
BRPI0810557A2 (pt)	2016-07-19	composição
BRPI0914793A2 (pt)	2015-08-04	Composição, e, uso de uma composição
BRPI0906253A2 (pt)	2015-06-30	Composição de dentifrício, e, uso de uma composição
EP2218701A4 (en)	2013-03-13	PIEZOELECTRIC CERAMIC COMPOSITION
DK2346679T3 (da)	2019-11-18	Forbedrede kompositmaterialer
EP2197828A4 (en)	2011-09-21	FULLERENE MULTI-ADDUCT COMPOSITIONS
EP2001817A4 (en)	2011-03-09	LIGHT CONCRETE COMPOSITIONS
BRPI0811002A2 (pt)	2015-01-27	Composição biofertilizante
BRPI0820960A2 (pt)	2017-05-09	composição
ZA201000667B (en)	2010-09-29	Anti-inflammatory composition
EP2119430A4 (en)	2013-08-14	PERLENDE COMPOSITION

Legal Events

Date	Code	Title	Description
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2020-06-23	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]	Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.
2020-09-29	B07G	Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
2020-10-20	B06U	Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
2021-02-02	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2021-04-06	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 06/04/2021, OBSERVADAS AS CONDICOES LEGAIS.